Nielsen, Claus H <br/><br/>
B-cell depletion with rituximab in the treatment of autoimmune diseases. Graves' ophthalmopathy the latest addition to an expanding family.  [electronic resource] 

 -  Expert opinion on biological therapy  Jul 2007 
 - 1061-78 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-7682 
<br/><br/><label>Standard No.: </label>10.1517/14712598.7.7.1061  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antigen-Presenting Cells--drug effects<br/>Autoantibodies--blood<br/>Autoimmune Diseases--drug therapy<br/>B-Lymphocytes--drug effects<br/>Graves Disease--drug therapy<br/>Graves Ophthalmopathy--drug therapy<br/>Humans<br/>Immunoglobulins--blood<br/>Lymphocyte Depletion<br/>Receptors, Thyrotropin--immunology<br/>Rituximab<br/>T-Lymphocytes--drug effects